Nurse phone calls may keep breast cancer patients safer on targeted therapy

NCT ID NCT07524829

Recruiting now Symptom relief Sponsor: Azienda Sanitaria Locale di Asti Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether regular phone or video calls from a trained oncology nurse can help breast cancer patients on CDK inhibitor drugs catch and manage side effects early. About 124 women will be randomly assigned to either standard care or standard care plus structured telenursing follow-up. The goal is to see if this approach reduces the number and severity of side effects, emergency visits, and treatment interruptions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Structured telenursing follow-up (telephone or video consultations by trained oncology nurses)
What this could lead to: If it works, this could provide a simple, home-based way to catch and manage side effects early, helping patients stay on treatment and avoid emergency visits.
What could go wrong: This is a relatively small, early-stage behavioral study, not testing a new drug. The benefit may be modest or hard to prove, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm chemotherapy-induced toxicity Drug-Related Side Effects and Adverse Reactions Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CHEMOTHERAPY TOXICITY DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS TREATMENT ADHERENCE TREATMENT-RELATED TOXICITY

Contacts and locations

Locations

Cardinal Massaia Hospital - S.C. Oncology, Azienda Sanitaria Locale AT (ASL AT)
RECRUITING

Asti, ASTI, 14100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.